Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0049 | 0.3779 | 0.3779 |
Echinococcus granulosus | 6 phosphofructokinase | 0.0105 | 1 | 1 |
Schistosoma mansoni | family S10 unassigned peptidase (S10 family) | 0.004 | 0.2748 | 0.2748 |
Loa Loa (eye worm) | hypothetical protein | 0.0017 | 0.0166 | 0.0166 |
Brugia malayi | Serine carboxypeptidase F41C3.5 precursor | 0.004 | 0.2748 | 0.2748 |
Mycobacterium ulcerans | long-chain fatty-acid CoA ligase | 0.0023 | 0.0814 | 0.0659 |
Brugia malayi | 6-phosphofructokinase | 0.0105 | 1 | 1 |
Echinococcus granulosus | lysosomal protective protein | 0.004 | 0.2748 | 0.2748 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0023 | 0.0814 | 0.0659 |
Entamoeba histolytica | pyrophosphate-dependent phosphofructokinase | 0.0028 | 0.1425 | 0.0666 |
Trypanosoma brucei | ATP-dependent 6-phosphofructokinase, glycosomal | 0.0105 | 1 | 1 |
Plasmodium vivax | 6-phosphofructokinase, putative | 0.0028 | 0.1425 | 1 |
Giardia lamblia | Pyrophosphate-fructose 6-phosphate 1-phosphotransferase alpha subunit | 0.0028 | 0.1425 | 0.5 |
Loa Loa (eye worm) | 6-phosphofructokinase | 0.0105 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0017 | 0.0166 | 0.0166 |
Treponema pallidum | diphosphate--fructose-6-phosphate 1-phosphotransferase | 0.0105 | 1 | 1 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD2 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0023 | 0.0814 | 0.0757 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0049 | 0.3779 | 0.3779 |
Plasmodium falciparum | ATP-dependent 6-phosphofructokinase | 0.0028 | 0.1425 | 1 |
Leishmania major | ATP-dependent phosphofructokinase | 0.0105 | 1 | 1 |
Entamoeba histolytica | phosphofructokinase, putative | 0.0105 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0814 | 0.0814 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0023 | 0.0814 | 0.0659 |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.203 | 0.203 |
Trypanosoma cruzi | ATP-dependent 6-phosphofructokinase, glycosomal | 0.0105 | 1 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0034 | 0.203 | 0.203 |
Mycobacterium tuberculosis | Probable chain -fatty-acid-CoA ligase FadD13 (fatty-acyl-CoA synthetase) | 0.0023 | 0.0814 | 0.0757 |
Trichomonas vaginalis | phosphofructokinase, putative | 0.0105 | 1 | 1 |
Plasmodium falciparum | ATP-dependent 6-phosphofructokinase | 0.0028 | 0.1425 | 1 |
Mycobacterium ulcerans | long-chain-fatty-acid-CoA ligase | 0.0023 | 0.0814 | 0.0659 |
Mycobacterium ulcerans | long-chain-fatty-acid--CoA ligase | 0.0023 | 0.0814 | 0.0659 |
Brugia malayi | AMP-binding enzyme family protein | 0.0023 | 0.0814 | 0.0814 |
Brugia malayi | AMP-binding enzyme family protein | 0.0023 | 0.0814 | 0.0814 |
Brugia malayi | 6-phosphofructokinase | 0.0105 | 1 | 1 |
Mycobacterium ulcerans | fatty-acid-CoA ligase | 0.0023 | 0.0814 | 0.0659 |
Entamoeba histolytica | phosphofructokinase, putative | 0.0105 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.3779 | 0.3779 |
Mycobacterium ulcerans | 6-phosphofructokinase | 0.0105 | 1 | 1 |
Plasmodium vivax | 6-phosphofructokinase, putative | 0.0028 | 0.1425 | 1 |
Toxoplasma gondii | 6-phosphofructokinase | 0.0028 | 0.1425 | 0.5 |
Mycobacterium tuberculosis | Fatty-acid-AMP ligase FadD30 (fatty-acid-AMP synthetase) (fatty-acid-AMP synthase) | 0.0017 | 0.0166 | 0.0105 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0023 | 0.0814 | 0.0659 |
Leishmania major | serine carboxypeptidase (CBP1), putative,serine peptidase, Clan SC, Family S10 | 0.004 | 0.2748 | 0.2106 |
Toxoplasma gondii | phosphofructokinase PFKII | 0.0028 | 0.1425 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0034 | 0.203 | 0.203 |
Loa Loa (eye worm) | phosphofructokinase | 0.0105 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0017 | 0.0166 | 0.0166 |
Mycobacterium tuberculosis | Probable 6-phosphofructokinase PfkA (phosphohexokinase) (phosphofructokinase) | 0.0105 | 1 | 1 |
Schistosoma mansoni | 6-phosphofructokinase | 0.0105 | 1 | 1 |
Onchocerca volvulus | Uncharacterized serine carboxypeptidase homolog | 0.004 | 0.2748 | 1 |
Echinococcus granulosus | family S10 non peptidase ue S10 family | 0.0036 | 0.2304 | 0.2304 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0814 | 0.0814 |
Trichomonas vaginalis | phosphofructokinase, putative | 0.0105 | 1 | 1 |
Chlamydia trachomatis | fructose-6-phosphate phosphotransferase | 0.0028 | 0.1425 | 1 |
Echinococcus multilocularis | family S10 non peptidase ue (S10 family) | 0.0036 | 0.2304 | 0.2304 |
Chlamydia trachomatis | fructose-6-phosphate phosphotransferase | 0.0028 | 0.1425 | 1 |
Schistosoma mansoni | family S10 non-peptidase homologue (S10 family) | 0.004 | 0.2748 | 0.2748 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0049 | 0.3779 | 0.3779 |
Mycobacterium leprae | PROBABLE 6-PHOSPHOFRUCTOKINASE PFKA (PHOSPHOHEXOKINASE) (PHOSPHOFRUCTOKINASE) | 0.0105 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.004 | 0.2748 | 0.2748 |
Loa Loa (eye worm) | hypothetical protein | 0.0017 | 0.0166 | 0.0166 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0814 | 0.0814 |
Loa Loa (eye worm) | hypothetical protein | 0.0017 | 0.0166 | 0.0166 |
Trichomonas vaginalis | phosphofructokinase, putative | 0.0105 | 1 | 1 |
Brugia malayi | AMP-binding enzyme family protein | 0.0023 | 0.0814 | 0.0814 |
Trichomonas vaginalis | phosphofructokinase, putative | 0.0105 | 1 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.0023 | 0.0814 | 0.0659 |
Schistosoma mansoni | 6-phosphofructokinase | 0.0105 | 1 | 1 |
Echinococcus multilocularis | lysosomal protective protein | 0.004 | 0.2748 | 0.2748 |
Loa Loa (eye worm) | 6-phosphofructokinase | 0.0105 | 1 | 1 |
Entamoeba histolytica | phosphofructokinase, putative | 0.0105 | 1 | 1 |
Echinococcus multilocularis | 6 phosphofructokinase | 0.0105 | 1 | 1 |
Toxoplasma gondii | phosphofructokinase domain-containing protein | 0.0028 | 0.1425 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MDA-N Breast cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the DU-145 Prostate cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.